What puzzles me is why run these efficacy trials at all if the end product is still a cosmetic? We've already run about a years worth of tests for efficacy and safety. IRB is a Gold Standard worldwide. Is Germany requiring more for efficacy? For a cosmetic? It doesn't add up IMO
And who is going to pay for them? We don't have the money. I hope we get some guidance and clarity from the company. This only makes sense if we're making a drug IMO.